Joyce Andrew, Berbatis Constantine G, Sunderland V Bruce, Dhaliwal Satvinder S
School of Pharmacy and School of Public Health, Curtin University of Technology, Perth, Western Australia, Australia.
Aust N Z J Public Health. 2007 Dec;31(6):516-9. doi: 10.1111/j.1753-6405.2007.00135.x.
To analyse the prevalence and factors associated with the provision of primary preventive services for cardiovascular disease (CVD) in Australia's community pharmacies.
The data were from the 2002 Australia's National Pharmacy Database Project. Questionnaires were completed by a nationally representative 1,131 out of a possible 1,391 pharmacies (81.3% response rate), stratified into PhARIA (remoteness) zones. Preventive services for CVD were analysed by frequency of provision of services. Ordinal analysis and logistic regression analysis were used to ascertain predictors of services.
Most community pharmacies initiated nicotine replacement therapies, 58.1% provided blood pressure screening, 11.6% anthropometric tests and 7.6% blood cholesterol screening. Pharmacies in promotional groups, having high customer numbers, an enclosed counselling area, or forward pharmacy area, were significantly associated with providing preventive services for CVD.
The configuration and size of Australia's community pharmacies were associated with providing primary preventive services for CVD.
分析澳大利亚社区药房提供心血管疾病（CVD）初级预防服务的患病率及相关因素。
数据来自2002年澳大利亚国家药房数据库项目。在可能的1391家药房中，有1131家（回复率81.3%）完成了问卷调查，这些药房按PhARIA（偏远程度）区域分层。通过服务提供频率分析心血管疾病的预防服务。采用有序分析和逻辑回归分析来确定服务的预测因素。
大多数社区药房开展了尼古丁替代疗法，58.1%提供血压筛查，11.6%提供人体测量测试，7.6%提供血液胆固醇筛查。促销组中的药房、顾客数量多、有封闭咨询区域或前方药房区域的药房，与提供心血管疾病预防服务显著相关。
澳大利亚社区药房的布局和规模与提供心血管疾病初级预防服务有关。
Zotero 插件